“Clinical Grade: “Our lab accreditation process greatly benefited from using a compliant and accredited software platform. ”
” Lisbeth Nørum Pedersen, Quality Manager at MOMA, MOMA, Denmark
“Robustness: “An invaluable tool for rapid, accurate and reproducible reporting.” ”
Prof. Joris Vermeesch, Head of Molecular Cytogenetics & Coordinator Genomics Core, UZ Leuven, Belgium
“Ease of Use: “all variant assessment information at one click of a button.” ”
Dominic McMullan, Principal Clinical Scientist at WMRGL, Birmingham, UK
“Efficiency: “With Cartagenia, we quadrupled our lab’s throughput.” ”
Alexander Zink, MD, Life & Brain, Bonn, Germany
“Cartagenia and Agilent Technologies Announce Global Distribution Agreement for Bench Lab CNV.”
Confidently interpret, report and share genomic variants.
Reduce turnaround time. Generate clinical grade lab reports. Manage increasing volumes of data.
Cartagenia enables genetic labs to perform clinically relevant analyses quickly and efficiently. Our solutions are rich in features, easy to use and secure, and work with diverse knowledge sources to integrate the interpretation of genomic variation in routine diagnostics.Discover our Solutions
We are cloud-based and scalable, and integrated into the global genetics diagnostics ecosystem. We are a collaborative platform, built not only to collect, sort, and secure the rush of data, but to listen and help you analyze it quickly, efficiently, effectively, intelligently.How we work
Our products are FDA registered in the US as exempt Class I Medical Devices and in Europe as Class I Medical Devices. We operate globally in accordance with a certified ISO13485 Quality Management System.Read more on cloud security and platform certification
Events and latest news
Nederlandse Vereniging voor Humane Genetica
Papendal, Arnhem The Netherlands
ASHG; American Society of Human Genetics, 2014.10.18 - 2014.10.22 , San Diego - USA
San Diego, USA
Cartagenia Bench: enhance your service delivery by confidently interpreting, sharing and reporting genomic variants.
Cartagenia and Agilent Technologies Announce Global Distribution Agreement for CNV Analysis to assist Cytogenetic Labs in the Clinical Interpretation of Microarray Data.